Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection

被引:57
作者
Watanabe, H
Enomoto, N
Nagayama, K
Izumi, N
Marumo, F
Sato, C
Watanabe, M
机构
[1] Tokyo Med & Dent Univ, Fac Med, Dept Gastroenterol & Hepatol, Dept Internal Med 2,Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Fac Med, Dept Hlth Sci, Tokyo 1138519, Japan
[3] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
关键词
D O I
10.1086/319674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To explore the relationship between responses to interferon (IFN) and the mutation patterns in the IFN sensitivity-determining region (ISDR; amino acid positions 2209-2248) in the NS5A gene of hepatitis C virus genotype 1b, a cohort of 334 patients was analyzed. The number of mutations in the ISDR was higher in patients with sustained response (SR) than in patients with transient or no response (P < .001). Patients with viruses mutated at positions 2209 (P = .02), 2216 (P = .01), or 2227 (P = .02) more frequently experienced SR than did those without these mutations. Mutation occurred most frequently at position 2218, where the presence of cysteine was significantly associated with SR. Thus, the mutation pattern in the ISDR affects the virologic response to IFN and reflects different influences on the function of the NS5A protein. ISDR sequence analysis would allow the prediction of clinical IFN efficacy in individual patients.
引用
收藏
页码:1195 / 1203
页数:9
相关论文
共 54 条
[21]  
Gale MJ, 1998, CLIN DIAGN VIROL, V10, P157
[22]   Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein [J].
Gale, MJ ;
Korth, MJ ;
Tang, NM ;
Tan, SL ;
Hopkins, DA ;
Dever, TE ;
Polyak, SJ ;
Gretch, DR ;
Katze, MG .
VIROLOGY, 1997, 230 (02) :217-227
[23]   Hepatitis C virus NSSA protein protects against TNF-α mediated apoptotic cell death [J].
Ghosh, AK ;
Majumder, M ;
Steele, R ;
Meyer, K ;
Ray, R ;
Ray, RB .
VIRUS RESEARCH, 2000, 67 (02) :173-178
[24]   Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway [J].
Heim, MH ;
Moradpour, D ;
Blum, HE .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8469-8475
[25]  
Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO
[26]  
2-C
[27]  
Ibarrola N, 1999, AM J GASTROENTEROL, V94, P2487
[28]   Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C [J].
Kasahara, A ;
Hayashi, N ;
Mochizuki, K ;
Takayanagi, M ;
Yoshioka, K ;
Kakumu, S ;
Iijima, A ;
Urushihara, A ;
Kiyosawa, K ;
Okuda, M ;
Hino, K ;
Okita, K .
HEPATOLOGY, 1998, 27 (05) :1394-1402
[29]   Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator [J].
Kato, N ;
Lan, KH ;
OnoNita, SK ;
Shiratori, Y ;
Omata, M .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8856-8859
[30]   MOLECULAR-CLONING OF THE HUMAN HEPATITIS-C VIRUS GENOME FROM JAPANESE PATIENTS WITH NON-A, NON-B HEPATITIS [J].
KATO, N ;
HIJIKATA, M ;
OOTSUYAMA, Y ;
NAKAGAWA, M ;
OHKOSHI, S ;
SUGIMURA, T ;
SHIMOTOHNO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9524-9528